SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87 | -59.3% | 145,351 | -11.9% | 0.00% | – |
| Q2 2023 | $214 | -67.9% | 165,019 | -56.5% | 0.00% | – |
| Q1 2023 | $666 | -57.5% | 379,016 | -24.0% | 0.00% | -100.0% |
| Q4 2022 | $1,566 | -99.9% | 498,464 | +36.4% | 0.00% | -50.0% |
| Q3 2022 | $1,791,000 | +318.5% | 365,540 | +253.8% | 0.00% | – |
| Q2 2022 | $428,000 | +14.4% | 103,306 | +60.1% | 0.00% | – |
| Q1 2022 | $374,000 | -87.3% | 64,533 | -83.6% | 0.00% | -100.0% |
| Q4 2021 | $2,954,000 | +161.9% | 393,852 | +214.8% | 0.00% | – |
| Q3 2021 | $1,128,000 | -28.0% | 125,127 | -4.4% | 0.00% | -100.0% |
| Q2 2021 | $1,566,000 | -52.5% | 130,844 | -50.3% | 0.00% | -50.0% |
| Q1 2021 | $3,297,000 | -42.3% | 263,087 | -28.2% | 0.00% | -33.3% |
| Q4 2020 | $5,716,000 | +59.8% | 366,258 | -3.2% | 0.00% | +50.0% |
| Q3 2020 | $3,578,000 | +6.5% | 378,527 | +0.9% | 0.00% | 0.0% |
| Q2 2020 | $3,361,000 | +48.3% | 375,194 | +5.4% | 0.00% | +100.0% |
| Q1 2020 | $2,267,000 | -19.1% | 355,813 | +6.3% | 0.00% | 0.0% |
| Q4 2019 | $2,802,000 | -4.8% | 334,772 | +2.9% | 0.00% | 0.0% |
| Q3 2019 | $2,944,000 | -32.6% | 325,432 | -19.8% | 0.00% | -50.0% |
| Q2 2019 | $4,368,000 | +69.0% | 405,591 | +49.7% | 0.00% | +100.0% |
| Q1 2019 | $2,585,000 | -9.4% | 270,982 | +9.1% | 0.00% | -66.7% |
| Q4 2018 | $2,852,000 | -38.0% | 248,438 | -8.5% | 0.00% | 0.0% |
| Q3 2018 | $4,602,000 | -7.8% | 271,574 | -22.7% | 0.00% | -25.0% |
| Q2 2018 | $4,991,000 | +29.1% | 351,539 | +72.9% | 0.00% | +100.0% |
| Q1 2018 | $3,865,000 | +35.2% | 203,360 | +16.6% | 0.00% | 0.0% |
| Q4 2017 | $2,859,000 | +18.2% | 174,385 | +8.2% | 0.00% | -33.3% |
| Q3 2017 | $2,418,000 | +26.6% | 161,155 | -25.8% | 0.00% | +50.0% |
| Q2 2017 | $1,910,000 | +226.5% | 217,108 | +93.2% | 0.00% | – |
| Q1 2017 | $585,000 | +34.5% | 112,383 | -21.2% | 0.00% | – |
| Q4 2016 | $435,000 | -6.0% | 142,623 | +42.6% | 0.00% | – |
| Q3 2016 | $463,000 | +215.0% | 100,043 | +293.9% | 0.00% | – |
| Q2 2016 | $147,000 | -52.1% | 25,399 | -50.4% | 0.00% | – |
| Q1 2016 | $307,000 | -71.6% | 51,163 | -57.5% | 0.00% | -100.0% |
| Q4 2015 | $1,081,000 | +70.0% | 120,300 | -5.3% | 0.00% | 0.0% |
| Q3 2015 | $636,000 | -69.2% | 127,070 | -32.3% | 0.00% | -50.0% |
| Q2 2015 | $2,066,000 | -35.4% | 187,775 | -11.9% | 0.00% | -50.0% |
| Q1 2015 | $3,200,000 | +3.7% | 213,237 | +3.7% | 0.00% | 0.0% |
| Q4 2014 | $3,086,000 | +113.6% | 205,643 | +42.2% | 0.00% | +300.0% |
| Q3 2014 | $1,445,000 | -9.6% | 144,566 | +35.7% | 0.00% | -50.0% |
| Q2 2014 | $1,599,000 | -87.7% | 106,548 | -85.3% | 0.00% | -86.7% |
| Q1 2014 | $13,033,000 | +105.0% | 724,031 | +48.0% | 0.02% | +150.0% |
| Q4 2013 | $6,359,000 | +432.6% | 489,075 | +309.5% | 0.01% | +200.0% |
| Q3 2013 | $1,194,000 | +57.3% | 119,423 | +22.9% | 0.00% | – |
| Q2 2013 | $759,000 | – | 97,141 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |